---
title: "Sensus Healthcare 1Q 2026: Revenue $3.39M, EPS $(0.16) — 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286304731.md"
description: "Sensus Healthcare, Inc. reported a revenue of $3.39M for Q1 2026, a 59% decline from $8.34M in Q1 2025, with a net loss of $2.63M and diluted EPS of $(0.16), unchanged from the previous year. The revenue drop was attributed to fewer unit sales and a shift towards long-term deals. The company reduced operating expenses and has sufficient cash to cover at least 12 months, while inventory increased in anticipation of future sales."
datetime: "2026-05-13T18:51:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286304731.md)
  - [en](https://longbridge.com/en/news/286304731.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286304731.md)
---

# Sensus Healthcare 1Q 2026: Revenue $3.39M, EPS $(0.16) — 10-Q Summary

Sensus Healthcare, Inc. reported first-quarter 2026 results with revenue of $3.39M, down from $8.34M a year earlier, and a net loss attributable to stockholders of $2.63M; diluted EPS was $(0.16), unchanged from the prior-year quarter.

**Financial Highlights**

-   Revenue was $3.39M for Q1 2026, compared with $8.34M in Q1 2025; YoY change (59.0%).
-   Net income was a loss of $2.63M attributable to stockholders for Q1 2026, versus a loss of $2.57M in Q1 2025.
-   Diluted EPS was $(0.16) for Q1 2026, unchanged from $(0.16) in Q1 2025.

**Business Highlights**

-   Revenue decline of 59% was driven by fewer unit sales and a shift toward deals recognized over time, including more Fair Deal Agreements and rentals.
-   Higher mix of international shipments and upfront costs tied to Fair Deals reduced gross margin.
-   Company reduced operating spend — G&A, sales and marketing, and R&D — reflecting fewer tradeshows, lower lobbying, reduced headcount and slowed product development.
-   Cash on hand is sufficient to cover at least 12 months; inventory increased in anticipation of future sales despite seasonal variability.

Original SEC Filing: Sensus Healthcare, Inc. \[ SRTS \] - 10-Q - May. 13, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [SRTS.US](https://longbridge.com/en/quote/SRTS.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)

## Related News & Research

- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business](https://longbridge.com/en/news/286889480.md)
- [Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal](https://longbridge.com/en/news/286808399.md)
- [Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results](https://longbridge.com/en/news/286942821.md)
- [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)